197 related articles for article (PubMed ID: 15151266)
1. The relationship between reticulocyte hemoglobin content with C-reactive protein and conventional iron parameters in dialysis patients.
Hackeng CM; Beerenhout CM; Hermans M; Van der Kuy PH; Van der Dussen H; Van Dieijen-Visser MP; Hamulyák K; Van der Sande FM; Leunissen KM; Kooman JP
J Nephrol; 2004; 17(1):107-11. PubMed ID: 15151266
[TBL] [Abstract][Full Text] [Related]
2. Role of C-reactive protein, reticulocyte haemoglobin content and inflammatory markers in iron and erythropoietin administration in dialysis patients.
El-Khatib M; Duncan HJ; Kant KS
Nephrology (Carlton); 2006 Oct; 11(5):400-4. PubMed ID: 17014552
[TBL] [Abstract][Full Text] [Related]
3. Reticulocyte hemoglobin content in hemodialysis patients with acute infection.
Mitsuiki K; Harada A; Miyata Y
Clin Exp Nephrol; 2004 Sep; 8(3):257-62. PubMed ID: 15480904
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of reticulocyte haemoglobin content as marker of iron deficiency and predictor of response to intravenous iron in haemodialysis patients.
Kim JM; Ihm CH; Kim HJ
Int J Lab Hematol; 2008 Feb; 30(1):46-52. PubMed ID: 18190467
[TBL] [Abstract][Full Text] [Related]
5. Soluble transferrin receptors and reticulocyte hemoglobin concentration in the assessment of iron deficiency in hemodialysis patients.
Fusaro M; Munaretto G; Spinello M; Rebeschini M; Amici G; Gallieni M; Piccoli A
J Nephrol; 2005; 18(1):72-9. PubMed ID: 15772926
[TBL] [Abstract][Full Text] [Related]
6. Assessment of iron deficiency in chronic hemodialysis patients: investigation of cutoff values for reticulocyte hemoglobin content.
Mitsuiki K; Harada A; Miyata Y
Clin Exp Nephrol; 2003 Mar; 7(1):52-7. PubMed ID: 14586744
[TBL] [Abstract][Full Text] [Related]
7. Discrepancy between the percentage of hypochromic erythrocytes and the reticulocyte hemoglobin content in hemodialysis patients with recombinant human erythropoietin therapy.
Asanuma M; Taguchi C; Uesaka H; Kumagai T; Seino K; Hosokawa H; Yamauchi F; Fujishima M; Murai K; Ishida Y
Lab Hematol; 2005; 11(2):124-30. PubMed ID: 16024336
[TBL] [Abstract][Full Text] [Related]
8. [Measuring the content of reticulocyte hemoglobin (CHr) in predialysis chronic renal failure (CRF) patients].
Saito M; Tsuchiya K; Ando M; Akiba T; Nihei H
Nihon Jinzo Gakkai Shi; 2003 Jul; 45(5):430-8. PubMed ID: 14509218
[TBL] [Abstract][Full Text] [Related]
9. Role of prohepcidin, inflammatory markers and iron status in resistance to rhEPO therapy in hemodialysis patients.
Costa E; Pereira BJ; Rocha-Pereira P; Rocha S; Reis F; Castro E; Teixeira F; Miranda V; do Sameiro Faria M; Loureiro A; Quintanilha A; Belo L; Santos-Silva A
Am J Nephrol; 2008; 28(4):677-83. PubMed ID: 18354252
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of measuring reticulocyte hemoglobin equivalent in the management of haemodialysis patients with iron deficiency.
Miwa N; Akiba T; Kimata N; Hamaguchi Y; Arakawa Y; Tamura T; Nitta K; Tsuchiya K
Int J Lab Hematol; 2010 Apr; 32(2):248-55. PubMed ID: 19624802
[TBL] [Abstract][Full Text] [Related]
11. Monitoring the content of reticulocyte hemoglobin (CHr) as the progression of anemia in nondialysis chronic renal failure (CRF) patients.
Tsuchiya K; Saito M; Okano-Sugiyama H; Nihei H; Ando M; Teramura M; Iwamoto YS; Shimada K; Akiba T
Ren Fail; 2005; 27(1):59-65. PubMed ID: 15717636
[TBL] [Abstract][Full Text] [Related]
12. Influence of inflammation on the relation between markers of iron deficiency in renal replacement therapy.
Yavuz A; Akbaş SH; Tuncer M; Kolağasi O; Cetinkaya R; Gürkan A; Demirbaş A; Gultekin M; Akaydin M; Ersoy F; Yakupoğlu G
Transplant Proc; 2004; 36(1):41-3. PubMed ID: 15013295
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of reticulocyte hemoglobin content, percentage of hypochromic red blood cells, and ratio of serum transferrin receptor level/serum iron level as markers of iron-deficiency erythropoiesis in patients undergoing hemodialysis].
Hasegawa M; Kawamura N; Koide S; Murase M; Asano S; Toba T; Kushimoto H; Murakami K; Tomita M; Hasegawa H; Shikano M; Mizuno M; Funahashi N; Kawashima S; Sugiyama S
Nihon Jinzo Gakkai Shi; 2002; 44(5):453-63. PubMed ID: 12216478
[TBL] [Abstract][Full Text] [Related]
14. Evaluating iron status in hemodialysis patients.
Enders HM
Nephrol Nurs J; 2002 Aug; 29(4):366-70. PubMed ID: 12224370
[TBL] [Abstract][Full Text] [Related]
15. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients.
Chen YC; Hung SC; Tarng DC
Am J Kidney Dis; 2006 Jun; 47(6):1036-44. PubMed ID: 16731299
[TBL] [Abstract][Full Text] [Related]
16. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
Attallah N; Osman-Malik Y; Frinak S; Besarab A
Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942
[TBL] [Abstract][Full Text] [Related]
17. Monitoring iron status in end-stage renal disease patients on hemodialysis.
Rafi A; Karkar A; Abdelrahman M
Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):73-8. PubMed ID: 17237895
[TBL] [Abstract][Full Text] [Related]
18. [Role of iron deficiency in erythropoietin sensitivity in dialysis patients with elevated C-reactive protein].
Martone M; Zanchi R; Panzetta G
G Ital Nefrol; 2003; 20(1):31-7. PubMed ID: 12647284
[TBL] [Abstract][Full Text] [Related]
19. Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEPO.
Mittman N; Sreedhara R; Mushnick R; Chattopadhyay J; Zelmanovic D; Vaseghi M; Avram MM
Am J Kidney Dis; 1997 Dec; 30(6):912-22. PubMed ID: 9398141
[TBL] [Abstract][Full Text] [Related]
20. Diagnosing and treating anemia and iron deficiency in hemodialysis patients.
Foret JP
Nephrol Nurs J; 2002 Jun; 29(3):292-6. PubMed ID: 12164080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]